Biogen Inc. (BIIB) vs Mettler-Toledo International Inc. (MTD)
BIIB and MTD are evenly matched — 7 metrics each of 14.
A side-by-side comparison of Biogen Inc. and Mettler-Toledo International Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 14, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
BIIB
Biogen Inc.
$200.05Healthcare
MTD
Mettler-Toledo International Inc.
$1131.49Healthcare
Total return — BIIB vs MTD
growth of $100 · last 29yBIIB +3228.4%MTD +7506.7%MTD compounded faster
BIIB MTD
BIIB vs MTD: by the numbers
- •BIIB is the larger company ($29.53B vs $22.86B market cap).
- •BIIB trades at the lower earnings multiple (21.42 vs 26.49 P/E).
- •MTD converts more revenue to profit (21.40% vs 13.92% net margin).
- •MTD grew revenue faster over the past five years (4.77% vs -4.80% CAGR).
Which is better, BIIB or MTD?
Metric tally: BIIB 7 · MTD 7It depends on what you're optimizing for:
ValueBIIB(lower P/E)
GrowthMTD(faster 5Y revenue CAGR)
QualityMTD(higher ROIC)
Metrics side by side
Valuation
| Metric | BIIB | MTD |
|---|---|---|
| P/E ratio | 21.42● | 26.49 |
| Forward P/E | 12.26● | 22.12 |
| P/S ratio | 3.01● | 5.61 |
| P/B ratio | 1.59 | — |
| PEG ratio | — | 8.96 |
| EV / EBITDA | 12.16● | 20.60 |
| FCF yield | 8.83%● | 3.46% |
Profitability
| Metric | BIIB | MTD |
|---|---|---|
| Gross margin | 69.77%● | 57.79% |
| Operating margin | 15.65% | 28.00%● |
| Net margin | 13.92% | 21.40%● |
| ROE | 7.36%● | -3677.41% |
| ROIC | 6.62% | 35.46%● |
Growth (annualized)
| Metric | BIIB | MTD |
|---|---|---|
| Revenue CAGR (5Y) | -4.80% | 4.77%● |
| EPS CAGR (5Y) | -18.67% | 10.81%● |
| FCF CAGR (5Y) | -3.59% | 1.98%● |
| Total return CAGR (5Y) | -12.79% | -3.11%● |
Frequently asked
- Which is better, BIIB or MTD?
- It depends on your goal. value: BIIB (lower P/E); growth: MTD (faster 5Y revenue CAGR); quality: MTD (higher ROIC). Across all compared metrics, they are evenly matched.
- Is BIIB or MTD cheaper?
- On trailing earnings, BIIB is cheaper: BIIB trades at a 21.42 P/E and MTD at 26.49.
- Which has grown faster, BIIB or MTD?
- Over the past five years, MTD grew revenue faster — BIIB at a -4.80% CAGR versus MTD at 4.77%.
- Is BIIB or MTD more profitable?
- MTD runs the higher net margin — BIIB at 13.92% versus MTD at 21.40%.
- Which has been the better investment, BIIB or MTD?
- Over the past 10-year, MTD delivered the higher annualized total return — BIIB at -2.05% versus MTD at 11.59%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Biogen P/E ratioMettler-Toledo International P/E ratioBiogen dividend yieldMettler-Toledo International dividend yieldBiogen ROEMettler-Toledo International ROEBiogen operating marginMettler-Toledo International operating marginBiogen revenue growthMettler-Toledo International revenue growthBiogen free cash flowMettler-Toledo International free cash flow
Biogen & Mettler-Toledo International appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 14, 2026.